Login
Subscribe
In the article “Mindfulness as an Alternative to the Antidepressant Medication Escitalopram for Anxiety Disorder” in the July issue of Worst Pills, Best Pills News,[1] we discussed a draft recommendation for screening for anxiety disorders by the U.S. Preventive Services Task Force (USPSTF). Subsequently, the USPSTF finalized its recommendation to screen adults 64 years or younger for anxiety disorders. Citing insufficient evidence of benefit, the USPSTF did not recommend screening adults 65...
In the article “Mindfulness as an Alternative to the Antidepressant Medication Escitalopram for Anxiety Disorder” in the July issue of Worst Pills, Best Pills News,[1] we discussed a draft recommendation for screening for anxiety disorders by the U.S. Preventive Services Task Force (USPSTF). Subsequently, the USPSTF finalized its recommendation to screen adults 64 years or younger for anxiety disorders. Citing insufficient evidence of benefit, the USPSTF did not recommend screening adults 65 years or older.[2] These recommendations may lead to more people seeking medical treatment for anxiety disorder. People with anxiety disorders should discuss with their clinicians whether nonpharmacological treatment options, such as psychotherapy or mindfulness-based interventions, are a good option.
References
[1] Worst Pills, Best Pills News. Mindfulness as an alternative to the antidepressant medication escitalopram for anxiety disorder. July 2023. https://www.worstpills.org/newsletters/view/1540. Accessed July 1, 2023.
[2] U.S. Preventive Services Task Force. Final recommendation statement. Anxiety disorders in adults: screening. June 20, 2023. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/anxiety-adults-screening. Accessed June 22, 2023.
